Stratos Wealth Partners’s Altimmune ALT Stock Holding History

Stratos Wealth Partners’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1	Closed	–	–	915
2018 Q3	$0	Buy	+1	New	+$11	﹤0.01%	2958

Other funds holding ALT

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

OAM

Oxford Asset Management Oxford, United Kingdom $232M AUM 31% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return

Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Stratos Wealth Partners's ALT Position: Q4 2018 in Review

Stratos Wealth Partners sold out of Altimmune (ALT) in Q4 2018, closing a stake of 1 share.

Stratos Wealth Partners first reported a position in ALT in Q3 2018 and held it in 1 quarter. The position peaked at $0 in Q3 2018. 23 funds tracked by Wall St. Rank hold ALT as of Q4 2018.

Stratos Wealth Partners reported no remaining Altimmune position as of Q4 2018 after selling out during the quarter.
Stratos Wealth Partners sold 1 Altimmune share in Q4 2018.
Stratos Wealth Partners first reported a position in Altimmune in Q3 2018 and held it in 1 quarter.
Stratos Wealth Partners's Altimmune position peaked at $0 in Q3 2018.
23 funds tracked by Wall St. Rank held Altimmune as of Q4 2018.

Based on Stratos Wealth Partners's 13F filing for Q4 2018, filed 8 Feb 2019.